These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12923677)

  • 1. [A review of side effects and complications with cannabinoid treatment].
    Radbruch L; Nauck F
    Schmerz; 2003 Aug; 17(4):274-9. PubMed ID: 12923677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of cannabinoids for the treatment of multiple sclerosis.
    Smith PF
    Expert Opin Drug Saf; 2005 May; 4(3):443-56. PubMed ID: 15934852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabinoids and mental health].
    Soyka M
    Schmerz; 2003 Aug; 17(4):268-73. PubMed ID: 12923676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
    Smith PF
    Expert Rev Neurother; 2007 Sep; 7(9):1157-63. PubMed ID: 17868014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cannabis use on health].
    Negrete JC
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):267-76. PubMed ID: 6324549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
    Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
    Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
    Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
    Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac side effects of psychiatric drugs.
    Mackin P
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():3-14. PubMed ID: 18098218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and effects of cannabis: a brief review.
    Ashton CH
    Br J Psychiatry; 2001 Feb; 178():101-6. PubMed ID: 11157422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
    Schwarcz G; Karajgi B; McCarthy R
    J Clin Psychopharmacol; 2009 Jun; 29(3):255-8. PubMed ID: 19440079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do cannabinoids have a role in cancer pain management?
    Farquhar-Smith WP
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):7-13. PubMed ID: 19262386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.